Opinion statement
There are three primary blood products that are often transfused in traumatic brain injury: packed red blood cells (pRBCs), platelets, and plasma. For pRBCs, hemoglobin thresholds for transfusion in anemia should be set at 7 g/dl. Higher threshold is warranted only when the patient is clinically symptomatic. For platelets, transfusion thresholds should be at least 50,000/mm3 for patients without and 100,000/mm3 for patients with evidence of hemorrhage. Reversal of antiplatelet therapy with platelet transfusion is advisable only in patients with active bleeding. Tests for platelet function are helpful in determining an adequate platelet transfusion in these situations. Fresh frozen plasma transfusion for correction of warfarin-induced coagulopathy is also advisable in patients with active bleeding. If available, activated factor VII can be used in refractory cases. Prothrombin concentrate complexes are also another alternative in refractory situations. Transfusion goals for patients with evidence of hemorrhage should be an international normalization ratio of 1.3 or less. Prophylactic transfusion of plasma in severe traumatic brain injury without intracranial hemorrhage has not been demonstrated to improve outcome. In all situations of product transfusion, patients should be closely observed for signs of volume overload and the development of transfusion-related acute lung injury. The benefit of product transfusion should always be weighed against the risk of a transfusion-related complication.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest published recently have been highlighted as: • Of importance •• Of major importance
Utter GH, Shahlaie K, Zwienenberg-Lee M, Muizelaar JP. Anemia in the setting of traumatic brain injury: the arguments for and against liberal transfusion. J Neurotrauma. 2011;28:155–65.
Weiskopf RB et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology. 2000;92:1646–52.
Lieberman JA et al. Critical oxygen delivery in conscious humans is less than 7.3 ml O2 × kg(-1) × min(-1). Anesthesiology. 2000;92:407–13.
Leung JM et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology. 2000;93:1004–10.
Czosnyka M, Smielewski P, Piechnik S, Steiner LA, Pickard JD. Cerebral autoregulation following head injury. J Neurosurg. 2001;95:756–63.
Cruz J, Jaggi JL, Hoffstad OJ. Cerebral blood flow and oxygen consumption in acute brain injury with acute anemia: an alternative for the cerebral metabolic rate of oxygen consumption? Crit Care Med. 1993;21:1218–24.
Todd MM, Wu B, Warner DS. The hemispheric cerebrovascular response to hemodilution is attenuated by a focal cryogenic brain injury. J Neurotrauma. 1994;11:149–60.
Graham DI et al. Ischaemic brain damage is still common in fatal non-missile head injury. J Neurol Neurosurg Psychiatry. 1989;52:346–50.
LeRoux P. Haemoglobin management in acute brain injury. Curr Opin Crit Care. 2013;19:83–91.
Malone DL et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma. 2003;54:898–905. discussion 905–907 (2003).
Hébert PC et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409–17.
Robertson CS et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014;312:36–47. This study is a randomized clinical trial that demonstrated no improvement in neurological outcome when hemoglobin concentration was maintained at least 10 g/dl.
Elterman J et al. Transfusion of red blood cells in patients with a prehospital Glasgow coma scale score of 8 or less and no evidence of shock is associated with worse outcomes. J Trauma Acute Care Surg. 2013;75:8–14. This study is a retrospective analysis of data from a clinical trial of hypertonic saline demonstrating that transfusion within the first 24 h was associated with a worse long-term neurological outcome in patient with severe traumatic brain injury and no shock.
Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among U.S. adults: behavioral risk factor surveillance system. Am J Prev Med. 2006;30:74–7.
Davis PK et al. Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy. Neurocrit Care. 2013;18:201–8.
Wong DK, Lurie F, Wong LL. The effects of clopidogrel on elderly traumatic brain injured patients. J Trauma. 2008;65:1303–8.
Ivascu FA et al. Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. J Trauma. 2008;65:785–8.
Nishijima DK, Zehtabchi S, Berrong J, Legome E. Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review. J Trauma Acute Care Surg. 2012;72:1658–63.
Washington CW, Schuerer DJE, Grubb RL. Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy. J Trauma. 2011;71:358–63.
Ohm C, Mina A, Howells G, Bair H, Bendick P. Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma. 2005;58:518–22.
McMillian WD, Rogers FB. Management of prehospital antiplatelet and anticoagulant therapy in traumatic head injury: a review. J Trauma. 2009;66:942–50.
Kaufman RM et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162:205–13. These clinical guidelines for platelet transfusion are the recommendations from the American Association of Blood Banks.
Engström M, Romner B, Schalén W, Reinstrup P. Thrombocytopenia predicts progressive hemorrhage after head trauma. J Neurotrauma. 2005;22:291–6.
Harhangi BS, Kompanje EJO, Leebeek FWG, Maas AIR. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008;150:165–75. discussion 175 (2008).
Liumbruno GM et al. Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus Trasfus Sangue. 2011;9:19–40.
Schnüriger B et al. The impact of platelets on the progression of traumatic intracranial hemorrhage. J Trauma. 2010;68:881–5.
Allard CB et al. Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. J Trauma. 2009;67:959–67.
Anglin CO et al. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. J Neurosurg. 2013;118:676–86. This study is a retrospective analysis of transfusion of blood products and neurological outcome in patients with mild to severe traumatic brain injury. Transfusion of FFP and/or pRBCs was associated with a worse neurological outcome.
Ivascu FA et al. Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality. J Trauma. 2005;59:1131–7. discussion 1137–1139 (2005).
Etemadrezaie H et al. The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg. 2007;109:166–71.
Mayer SA et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777–85.
White CE, Schrank AE, Baskin TW, Holcomb JB. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage. Curr Surg. 2006;63:310–7.
Morenski JD, Tobias JD, Jimenez DF. Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literature. J Neurosurg. 2003;98:611–6.
Joseph B et al. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury. J Trauma Acute Care Surg. 2013;74:248–53.
Johansen M, Wikkelsø A, Lunde J, Wetterslev J, Afshari A. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients. Cochrane Database Syst Rev. 2015;7:CD010555.
CRASH-2 trial collaborators et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet Lond Engl. 2010;376:23–32.
Perel P et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury—a nested randomised, placebo-controlled trial. Health Technol Assess Winch Engl. 2012;16(iii–xii):1–54.
Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang. 2005;89:1–10.
Stainsby D et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev. 2006;20:273–82.
Triulzi DJ. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg. 2009;108:770–6.
Clifford L et al. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology. 2015;122:21–8.
Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med. 2006;34:S109–113.
Compliance with Ethics Guidelines
Conflict of Interest
G. Duemani Reddy, Shankar Gopinath, and Claudia S. Robertson declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Critical Care Neurology
Rights and permissions
About this article
Cite this article
Reddy, G.D., Gopinath, S. & Robertson, C.S. Transfusion in Traumatic Brain Injury. Curr Treat Options Neurol 17, 46 (2015). https://doi.org/10.1007/s11940-015-0379-9
Published:
DOI: https://doi.org/10.1007/s11940-015-0379-9